[Remote] Executive Oncology Specialist - Eastern US at Illumina

United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Healthcare, OncologyIndustries

Requirements

Advanced degree, such as PhD, PharmD, MD, in oncology, molecular biology, genomics, or a related field (preferred); strong preference for clinical or translational oncology experience
Typically requires a minimum 8+ years of experience in oncology diagnostics, NGS, or related industry, ideally in a commercial, clinical affairs, or medical affairs role with a bachelor's degree
Deep understanding of molecular oncology, cancer genomics, and the clinical utility of NGS in oncology settings
Customer facing experience including engagement with executives, laboratory directors, and KOLs; oncology sales experience highly desired
Excellent communication, presentation, and interpersonal skills
Proven ability to work cross-functionally in a fast-paced, innovative environment
Willingness to travel up to 50% within the Americas

Responsibilities

Serve as a subject matter expert on oncology-focused sequencing applications, including somatic testing, liquid biopsy, tumor profiling, and minimal residual disease (MRD) monitoring
Drive market development and educational initiatives to support the adoption of Illumina’s oncology portfolio in hospitals, cancer centers, and reference laboratories
Partner with sales teams to identify opportunities, support customer engagement, and provide technical/scientific guidance during the sales cycle
Present scientific and clinical value propositions at webinars, workshops, and customer meetings
Collaborate with marketing to develop oncology-specific content, training, and campaigns tailored to customer segments
Analyze market trends, competitive landscape, and customer feedback to inform product development and go-to-market strategies
Support key opinion leader (KOL) engagement and manage strategic partnerships within the oncology community
Engage with third party partners to incorporate their solutions into the customer engagement process when appropriate
Contribute to periodic forecasts including creation of annual revenue plan for the oncology portfolio

Skills

Key technologies and capabilities for this role

oncology sequencingsomatic testingliquid biopsytumor profilingMRD monitoringgenomic technologiessales supportscientific presentationsmarket developmentcustomer engagement

Questions & Answers

Common questions about this position

What qualifications are preferred for the Executive Oncology Specialist role?

An advanced degree such as PhD, PharmD, or MD in oncology, molecular biology, genomics, or a related field is preferred, with strong preference for clinical or translational oncology experience. Typically requires a minimum of 8+ years of experience in oncology diagnostics, NGS, or related industry, ideally in commercial, clinical affairs, or medical affairs roles with a bachelor's degree. Deep understanding of molecular oncology, cancer genomics, and the clinical utility of NGS in oncology settings, plus customer-facing experience, are also key.

What is the salary or compensation for this position?

This information is not specified in the job description.

Is this role remote or does it require travel in the Eastern US?

This information is not specified in the job description.

What is the company culture like at Illumina?

Illumina emphasizes being part of something bigger than yourself, with every person in every role having the opportunity to make a difference. Employees are surrounded by extraordinary people, inspiring leaders, and world-changing projects, enabling them to do more and become more than they thought possible.

What makes a strong candidate for this Oncology Specialist position?

Strong candidates will have an advanced degree in a relevant field with clinical or translational oncology experience, 8+ years in oncology diagnostics or NGS in commercial roles, deep knowledge of cancer genomics and NGS utility, and proven customer-facing experience.

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free